Trazodone

Generic Name
Trazodone
Brand Names
Desyrel, Oleptro
Drug Type
Small Molecule
Chemical Formula
C19H22ClN5O
CAS Number
19794-93-5
Unique Ingredient Identifier
YBK48BXK30
Background

Trazodone is triazolopyridine derivative from the serotonin receptor antagonists and reuptake inhibitors (SARIs) class of antidepressants. It is used in adults and has been shown to be comparable in efficacy to other drugs such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine receptor inhibito...

Indication

Trazodone is indicated for the treatment of major depressive disorder (MDD). It has been used off-label for adjunct therapy in alcohol dependence, and off-label to treat anxiety and insomnia. It may also be used off-label to treat symptoms of dementia, Alzheimer’s disease, schizophrenia, eating disorders, and fibromyalgia due to its effects on various neurot...

Associated Conditions
Alcohol Dependency, Alzheimer's Disease (AD), Anxiety, Dementia, Eating Disorders Symptoms, Fibromyalgia, Insomnia, Major Depressive Disorder (MDD), Pain, Inflammatory, Schizophrenia, Moderate to severe pain
Associated Therapies
-

The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With Depression

First Posted Date
2019-11-14
Last Posted Date
2020-04-06
Lead Sponsor
Chang Gung Memorial Hospital
Target Recruit Count
22
Registration Number
NCT04162743
Locations
🇨🇳

Chang Gung Memorial Hospital, Keelung, Keelung, Taiwan

Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.

First Posted Date
2019-09-09
Last Posted Date
2022-05-12
Lead Sponsor
Erich Seifritz
Target Recruit Count
54
Registration Number
NCT04082806
Locations
🇨🇭

Psychiatric University Hospital, Zürich, ZH, Switzerland

National Adaptive Trial for PTSD Related Insomnia

Phase 3
Recruiting
Conditions
Interventions
First Posted Date
2018-09-12
Last Posted Date
2024-12-19
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
774
Registration Number
NCT03668041
Locations
🇺🇸

Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States

🇺🇸

Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, Alabama, United States

🇺🇸

Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona, United States

and more 32 locations

Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis

First Posted Date
2018-05-23
Last Posted Date
2024-02-05
Lead Sponsor
University of Washington
Target Recruit Count
126
Registration Number
NCT03534284
Locations
🇺🇸

Northwest Kidney Centers, Seattle, Washington, United States

Accuracy and Efficacy of Trazodone (Desyrel) on Sleep Quality and Pain Management of TMD Patient

First Posted Date
2018-05-11
Last Posted Date
2020-02-05
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Target Recruit Count
3
Registration Number
NCT03522207
Locations
🇨🇦

CHUM, Montréal, Quebec, Canada

Trazodone Dose Tolerance and APAP Adherence

Phase 1
Suspended
Conditions
Interventions
First Posted Date
2016-10-26
Last Posted Date
2020-05-11
Lead Sponsor
Louis Stokes VA Medical Center
Target Recruit Count
45
Registration Number
NCT02945644
Locations
🇺🇸

Louis Stokes Cleveland VA Medical Center, Cleveland, Ohio, United States

Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury

First Posted Date
2016-10-04
Last Posted Date
2023-11-03
Lead Sponsor
John D. Dingell VA Medical Center
Target Recruit Count
100
Registration Number
NCT02922894
Locations
🇺🇸

John D. Dingell VA Medical Center, Detroit, Michigan, United States

Obstructive Sleep Apnea and Arousal Threshold in Patients With Post-traumatic Stress Disorder

First Posted Date
2016-03-04
Last Posted Date
2019-07-10
Lead Sponsor
University of California, San Diego
Registration Number
NCT02699138
Locations
🇺🇸

University of California San Diego, San Diego, California, United States

© Copyright 2024. All Rights Reserved by MedPath